BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saito YA, Schoenfeld P, Locke GR 3rd. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002;97:1910-5. [PMID: 12190153 DOI: 10.1111/j.1572-0241.2002.05913.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 192] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Abid S, Rehman H, Awan S, Artani A, Siddiqui I. Epidemiology of functional gastrointestinal disorders using ROME III adult questionnaire, a population based cross sectional study in Karachi-Pakistan. PLoS One 2022;17:e0268403. [PMID: 35696397 DOI: 10.1371/journal.pone.0268403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Shobeiri P, Kalantari A, Teixeira AL, Rezaei N. Shedding light on biological sex differences and microbiota-gut-brain axis: a comprehensive review of its roles in neuropsychiatric disorders. Biol Sex Differ 2022;13:12. [PMID: 35337376 DOI: 10.1186/s13293-022-00422-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Oroian BA, Ciobica A, Timofte D, Stefanescu C, Serban IL. New Metabolic, Digestive, and Oxidative Stress-Related Manifestations Associated with Posttraumatic Stress Disorder. Oxid Med Cell Longev 2021;2021:5599265. [PMID: 34966477 DOI: 10.1155/2021/5599265] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Uçar IÇ, Esen F, Turhan SA, Oguz H, Ulasoglu HC, Aykut V. Corneal neuropathic pain in irritable bowel syndrome: clinical findings and in vivo corneal confocal microscopy. Graefes Arch Clin Exp Ophthalmol 2021. [PMID: 34184124 DOI: 10.1007/s00417-021-05269-y] [Reference Citation Analysis]
5 Sharma A, Rao SSC, Kearns K, Orleck KD, Waldman SA. Review article: diagnosis, management and patient perspectives of the spectrum of constipation disorders. Aliment Pharmacol Ther 2021;53:1250-67. [PMID: 33909919 DOI: 10.1111/apt.16369] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
6 Patel S, Doerfler B, Boutros K, Ng S, Manuel M, DeSimone E. Review of Treatment Options for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation. Int J Gen Med 2021;14:1457-68. [PMID: 33907450 DOI: 10.2147/IJGM.S274568] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Killian LA, Muir JG, Barrett JS, Burd NA, Lee SY. High Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Consumption Among Endurance Athletes and Relationship to Gastrointestinal Symptoms. Front Nutr 2021;8:637160. [PMID: 33959628 DOI: 10.3389/fnut.2021.637160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ligon CO, Hannig G, Greenwood‐van Meerveld B. Peripheral Guanylate Cyclase‐C modulation of corticolimbic activation and corticotropin‐releasing factor signaling in a rat model of stress‐induced colonic hypersensitivity. Neurogastroenterology & Motility 2021;33. [DOI: 10.1111/nmo.14076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 DeLeon C, Wang DQ, Arnatt CK. G Protein-Coupled Estrogen Receptor, GPER1, Offers a Novel Target for the Treatment of Digestive Diseases. Front Endocrinol (Lausanne) 2020;11:578536. [PMID: 33281743 DOI: 10.3389/fendo.2020.578536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Letsinger AC, Menon R, Iyer AR, Vellers HL, Granados JZ, Jayaraman A, Lightfoot JT. A High Fat/High Sugar Diet Alters the Gastrointestinal Metabolome in a Sex Dependent Manner. Metabolites 2020;10:E421. [PMID: 33092034 DOI: 10.3390/metabo10100421] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Preidis GA, Weizman AV, Kashyap PC, Morgan RL. AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology 2020;159:708-738.e4. [PMID: 32531292 DOI: 10.1053/j.gastro.2020.05.060] [Cited by in Crossref: 22] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
12 Xu S, Wang X, Zhao J, Yang S, Dong L, Qin B. GPER-mediated, oestrogen-dependent visceral hypersensitivity in stressed rats is associated with mast cell tryptase and histamine expression. Fundam Clin Pharmacol 2020;34:433-43. [PMID: 31967341 DOI: 10.1111/fcp.12537] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
13 Tao ZY, Wang PX, Wei SQ, Traub RJ, Li JF, Cao DY. The Role of Descending Pain Modulation in Chronic Primary Pain: Potential Application of Drugs Targeting Serotonergic System. Neural Plast 2019;2019:1389296. [PMID: 31933624 DOI: 10.1155/2019/1389296] [Cited by in Crossref: 9] [Cited by in F6Publishing: 83] [Article Influence: 3.0] [Reference Citation Analysis]
14 Pleasant V, Sammarco A, Keeney-Bonthrone G, Bell S, Saad R, Berger MB. Use of X-ray to Assess Fecal Loading in Patients with Gastrointestinal Symptoms. Dig Dis Sci 2019;64:3589-95. [PMID: 31388854 DOI: 10.1007/s10620-019-05770-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Mosińska P, Szczepaniak A, Wojciechowicz T, Skrzypski M, Nowak K, Fichna J. Chain length of dietary fatty acids determines gastrointestinal motility and visceromotor function in mice in a fatty acid binding protein 4-dependent manner. Eur J Nutr 2020;59:2481-96. [PMID: 31562532 DOI: 10.1007/s00394-019-02094-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Glover SC, Nouri MZ, Tuna KM, Mendoza Alvarez LB, Ryan LK, Shirley JF, Tang Y, Denslow ND, Alli AA. Lipidomic analysis of urinary exosomes from hereditary α-tryptasemia patients and healthy volunteers. FASEB Bioadv 2019;1:624-38. [PMID: 31803861 DOI: 10.1096/fba.2019-00030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
17 Kawamura Y, Yamamoto S, Funaki Y, Ohashi W, Yamamoto K, Ozeki T, Yamaguchi Y, Tamura Y, Izawa S, Hijikata Y, Ebi M, Ogasawara N, Sasaki M, Kasugai K. Internet survey on the actual situation of constipation in the Japanese population under 70 years old: focus on functional constipation and constipation-predominant irritable bowel syndrome. J Gastroenterol 2020;55:27-38. [PMID: 31428873 DOI: 10.1007/s00535-019-01611-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
18 Kesuma Y, Firmansyah A, Bardosono S, Sari IP, Kurniawan A. Blastocystis ST-1 is associated with Irritable Bowel Syndrome-diarrhoea (IBS-D) in Indonesian adolescences. Parasite Epidemiol Control 2019;6:e00112. [PMID: 31528737 DOI: 10.1016/j.parepi.2019.e00112] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
19 El-Salhy M, Gilja OH, Hatlebakk JG. Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting. Mol Med Rep. 2019;20:787-794. [PMID: 31180516 DOI: 10.3892/mmr.2019.10284] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
20 Ashktorab H, Soleimani A, Singh G, Amin A, Tabtabaei S, Latella G, Stein U, Akhondzadeh S, Solanki N, Gondré-Lewis MC, Habtezion A, Brim H. Saffron: The Golden Spice with Therapeutic Properties on Digestive Diseases. Nutrients 2019;11:E943. [PMID: 31027364 DOI: 10.3390/nu11050943] [Cited by in Crossref: 39] [Cited by in F6Publishing: 64] [Article Influence: 13.0] [Reference Citation Analysis]
21 Kolacz J, Kovacic KK, Porges SW. Traumatic stress and the autonomic brain-gut connection in development: Polyvagal Theory as an integrative framework for psychosocial and gastrointestinal pathology. Dev Psychobiol 2019;61:796-809. [PMID: 30953358 DOI: 10.1002/dev.21852] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
22 Wang XJ, Camilleri M. Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy. World J Gastroenterol 2019; 25(10): 1185-1196 [PMID: 30886502 DOI: 10.3748/wjg.v25.i10.1185] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
23 Li YJ, Dai C, Jiang M. Mechanisms of Probiotic VSL#3 in a Rat Model of Visceral Hypersensitivity Involves the Mast Cell-PAR2-TRPV1 Pathway. Dig Dis Sci. 2019;64:1182-1192. [PMID: 30560330 DOI: 10.1007/s10620-018-5416-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
24 Li J, Cui H, Cai Y, Lin J, Song X, Zhou Z, Xiong W, Zhou H, Bian Y, Wang L. Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation. Front Pharmacol. 2018;9:1110. [PMID: 30323765 DOI: 10.3389/fphar.2018.01110] [Cited by in Crossref: 14] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
25 Killian LA, Chapman-Novakofski KM, Lee SY. Questionnaire on Irritable Bowel Syndrome and Symptom Management Among Endurance Athletes Is Valid and Reliable. Dig Dis Sci 2018;63:3281-9. [PMID: 30232638 DOI: 10.1007/s10620-018-5289-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Lyons JJ. Hereditary Alpha Tryptasemia: Genotyping and Associated Clinical Features. Immunol Allergy Clin North Am 2018;38:483-95. [PMID: 30007465 DOI: 10.1016/j.iac.2018.04.003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 62] [Article Influence: 12.8] [Reference Citation Analysis]
27 Ligon C, Mohammadi E, Ge P, Hannig G, Higgins C, Greenwood‐van Meerveld B. Linaclotide inhibits colonic and urinary bladder hypersensitivity in adult female rats following unpredictable neonatal stress. Neurogastroenterol Motil 2018;30. [DOI: 10.1111/nmo.13375] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
28 Mohammadi EN, Ligon CO, Silos-Santiago A, Ge P, Kurtz C, Higgins C, Hannig G, Greenwood-Van Meerveld B. Linaclotide Attenuates Visceral Organ Crosstalk: Role of Guanylate Cyclase-C Activation in Reversing Bladder-Colon Cross-Sensitization. J Pharmacol Exp Ther 2018;366:274-81. [PMID: 29784661 DOI: 10.1124/jpet.118.248567] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
29 Tanaka Y, Kanazawa M, Palsson OS, Tilburg MAV, Gangarosa LM, Fukudo S, Drossman DA, Whitehead WE. Increased Postprandial Colonic Motility and Autonomic Nervous System Activity in Patients With Irritable Bowel Syndrome: A Prospective Study. J Neurogastroenterol Motil. 2018;24:87-95. [PMID: 29291610 DOI: 10.5056/jnm16216] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
30 Qi Q, Zhang Y, Chen F, Zuo X, Li Y. Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials. BMC Gastroenterol 2018;18:5. [PMID: 29310568 DOI: 10.1186/s12876-017-0734-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
31 Chatila R, Merhi M, Hariri E, Sabbah N, Deeb ME. Irritable bowel syndrome: prevalence, risk factors in an adult Lebanese population. BMC Gastroenterol 2017;17:137. [PMID: 29197339 DOI: 10.1186/s12876-017-0698-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
32 Kawoos Y, Wani ZA, Kadla SA, Shah IA, Hussain A, Dar MM, Margoob MA, Sideeq K. Psychiatric Co-morbidity in Patients With Irritable Bowel Syndrome at a Tertiary Care Center in Northern India. J Neurogastroenterol Motil 2017;23:555-60. [PMID: 28738451 DOI: 10.5056/jnm16166] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
33 Waehrens R, Zöller B, Sundquist J, Sundquist K, Pirouzifard M. A Swedish national adoption study of risk of irritable bowel syndrome (IBS). BMJ Open Gastroenterol 2017;4:e000156. [PMID: 29119001 DOI: 10.1136/bmjgast-2017-000156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
34 El-Salhy M, Gilja OH. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome. BMC Gastroenterol 2017;17:90. [PMID: 28764761 DOI: 10.1186/s12876-017-0643-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
35 Levio S, Cash BD. The place of eluxadoline in the management of irritable bowel syndrome with diarrhea. Therap Adv Gastroenterol 2017;10:715-25. [PMID: 28932272 DOI: 10.1177/1756283X17721152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
36 Marbury TC, Berg JK, Dove LS, Covington PS. Effect of Hepatic Impairment on Eluxadoline Pharmacokinetics. J Clin Pharmacol 2017;57:1454-9. [PMID: 28719721 DOI: 10.1002/jcph.964] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
37 Rostami A, Riahi SM, Haghighi A, Saber V, Armon B, Seyyedtabaei SJ. The role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis. Parasitol Res. 2017;116:2361-2371. [PMID: 28668983 DOI: 10.1007/s00436-017-5535-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 6.4] [Reference Citation Analysis]
38 Pohl CS, Medland JE, Mackey E, Edwards LL, Bagley KD, DeWilde MP, Williams KJ, Moeser AJ. Early weaning stress induces chronic functional diarrhea, intestinal barrier defects, and increased mast cell activity in a porcine model of early life adversity. Neurogastroenterol Motil 2017;29. [PMID: 28573751 DOI: 10.1111/nmo.13118] [Cited by in Crossref: 32] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
39 Bharucha AE, Chakraborty S, Sletten CD. Common Functional Gastroenterological Disorders Associated With Abdominal Pain. Mayo Clin Proc 2016;91:1118-32. [PMID: 27492916 DOI: 10.1016/j.mayocp.2016.06.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
40 Toghiani A, Maleki I, Afshar H, Kazemian A. Translation and validation of the Farsi version of Rome III diagnostic questionnaire for the adult functional gastrointestinal disorders. J Res Med Sci 2016;21:103. [PMID: 28250780 DOI: 10.4103/1735-1995.193175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
41 Buono JL, Carson RT, Flores NM. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes 2017;15:35. [PMID: 28196491 DOI: 10.1186/s12955-017-0611-2] [Cited by in Crossref: 81] [Cited by in F6Publishing: 99] [Article Influence: 16.2] [Reference Citation Analysis]
42 Sayuk GS, Wolf R, Chang L. Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome. Am J Gastroenterol 2017;112:892-9. [PMID: 28094313 DOI: 10.1038/ajg.2016.574] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
43 Bhattarai Y, Muniz Pedrogo DA, Kashyap PC. Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol. 2017;312:G52-G62. [PMID: 27881403 DOI: 10.1152/ajpgi.00338.2016] [Cited by in Crossref: 104] [Cited by in F6Publishing: 103] [Article Influence: 17.3] [Reference Citation Analysis]
44 Lyons JJ, Yu X, Hughes JD, Le QT, Jamil A, Bai Y, Ho N, Zhao M, Liu Y, O'Connell MP, Trivedi NN, Nelson C, DiMaggio T, Jones N, Matthews H, Lewis KL, Oler AJ, Carlson RJ, Arkwright PD, Hong C, Agama S, Wilson TM, Tucker S, Zhang Y, McElwee JJ, Pao M, Glover SC, Rothenberg ME, Hohman RJ, Stone KD, Caughey GH, Heller T, Metcalfe DD, Biesecker LG, Schwartz LB, Milner JD. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet 2016;48:1564-9. [PMID: 27749843 DOI: 10.1038/ng.3696] [Cited by in Crossref: 142] [Cited by in F6Publishing: 149] [Article Influence: 23.7] [Reference Citation Analysis]
45 Reichenbach ZW, Schey R. Cannabinoids and GI Disorders: Endogenous and Exogenous. Curr Treat Options Gastroenterol 2016;14:461-77. [PMID: 27699625 DOI: 10.1007/s11938-016-0111-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Cañón M, Ruiz AJ, Rondón M, Alvarado J. Prevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian University: an electronic survey. Ann Gastroenterol 2017;30:67-75. [PMID: 28042240 DOI: 10.20524/aog.2016.0093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
47 Lucak S, Chang L, Halpert A, Harris LA. Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice. Therap Adv Gastroenterol 2017;10:253-75. [PMID: 28203283 DOI: 10.1177/1756283X16663396] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
48 Tao W, Dong X, Kong G, Fang P, Huang X, Bo P. Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterol Res Pract 2016;2016:9256209. [PMID: 27635130 DOI: 10.1155/2016/9256209] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
49 Chu H, Fox M, Zheng X, Deng Y, Long Y, Huang Z, Du L, Xu F, Dai N. Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines. Gastroenterol Res Pract. 2016;2016:3230859. [PMID: 27379166 DOI: 10.1155/2016/3230859] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
50 Patel A, Hasak S, Cassell B, Ciorba MA, Vivio EE, Kumar M, Gyawali CP, Sayuk GS. Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 2016;44:246-58. [PMID: 27240555 DOI: 10.1111/apt.13677] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
51 Tang B, Zhang J, Yang Z, Lu Y, Xu Q, Chen X, Lin J. Moxibustion for Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med. 2016;2016:5105108. [PMID: 27293460 DOI: 10.1155/2016/5105108] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
52 Sbahi H, Di Palma JA. Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterol 2016;3:e000087. [PMID: 27239328 DOI: 10.1136/bmjgast-2016-000087] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
53 Ng KS, Nassar N, Hamd K, Nagarajah A, Gladman MA. Prevalence of functional bowel disorders and faecal incontinence: an Australian primary care survey. Colorectal Dis. 2015;17:150-159. [PMID: 25359460 DOI: 10.1111/codi.12808] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
54 Maagaard L, Ankersen DV, Végh Z, Burisch J, Jensen L, Pedersen N, Munkholm P. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol 2016; 22(15): 4009-4019 [PMID: 27099444 DOI: 10.3748/wjg.v22.i15.4009] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 74] [Article Influence: 14.2] [Reference Citation Analysis]
55 Novak KL, Jacob D, Kaplan GG, Boyce E, Ghosh S, Ma I, Lu C, Wilson S, Panaccione R. Point of Care Ultrasound Accurately Distinguishes Inflammatory from Noninflammatory Disease in Patients Presenting with Abdominal Pain and Diarrhea. Can J Gastroenterol Hepatol. 2016;2016:4023065. [PMID: 27446838 DOI: 10.1155/2016/4023065] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
56 Foxx-Orenstein AE. New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists. Therap Adv Gastroenterol 2016;9:354-75. [PMID: 27134665 DOI: 10.1177/1756283X16633050] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
57 Lacy BE. Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med. 2016;9:7-17. [PMID: 26929659 DOI: 10.2147/ijgm.s93698] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
58 Lacy BE. Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med. 2016;9:7-17. [PMID: 26929659 DOI: 10.2147/ijgm] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
59 Harrell CS, Gillespie CF, Neigh GN. Energetic stress: The reciprocal relationship between energy availability and the stress response. Physiol Behav 2016;166:43-55. [PMID: 26454211 DOI: 10.1016/j.physbeh.2015.10.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
60 Cash BD, Epstein MS, Shah SM. A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms. Dig Dis Sci. 2016;61:560-571. [PMID: 26319955 DOI: 10.1007/s10620-015-3858-7] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 12.1] [Reference Citation Analysis]
61 Bokic T, Storr M, Schicho R. Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview. Pharmacology. 2015;96:76-85. [PMID: 26139425 DOI: 10.1159/000435816] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
62 Oshima T, Miwa H. Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World. J Neurogastroenterol Motil. 2015;21:320-329. [PMID: 26095436 DOI: 10.5056/jnm14165] [Cited by in Crossref: 104] [Cited by in F6Publishing: 96] [Article Influence: 14.9] [Reference Citation Analysis]
63 Shahabi L, Naliboff BD, Shapiro D. Self-regulation evaluation of therapeutic yoga and walking for patients with irritable bowel syndrome: a pilot study. Psychol Health Med 2016;21:176-88. [PMID: 26086986 DOI: 10.1080/13548506.2015.1051557] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
64 Theodorou V, Ait Belgnaoui A, Agostini S, Eutamene H. Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome. Gut Microbes. 2014;5:430-436. [PMID: 25184834 DOI: 10.4161/gmic.29796] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
65 Nozu T, Okumura T. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome. J Gastroenterol. 2015;50:819-830. [PMID: 25962711 DOI: 10.1007/s00535-015-1086-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
66 Rusu F, Dumitrascu DL. Epidemiology of irritable bowel syndrome in the former communist countries from Eastern Europe: a systematic review. Clujul Med. 2015;88:146-151. [PMID: 26528063 DOI: 10.15386/cjmed-449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
67 Xiao Y, Liu Y, Huang S, Sun X, Tang Y, Cheng J, Wang T, Li F, Kuang Y, Luo R. The efficacy of Shugan Jianpi Zhixie therapy for diarrhea-predominant irritable bowel syndrome: a meta-analysis of randomized, double-blind, placebo-controlled trials. PLoS One. 2015;10:e0122397. [PMID: 25853241 DOI: 10.1371/journal.pone.0122397] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
68 Song J, Zhang L, Bai T, Qian W, Li R, Hou X. Mast Cell-dependent Mesenteric Afferent Activation by Mucosal Supernatant From Different Bowel Segments of Guinea Pigs With Post-infectious Irritable Bowel Syndrome. J Neurogastroenterol Motil 2015;21:236-46. [PMID: 25843076 DOI: 10.5056/jnm14095] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
69 Costanian C, Tamim H, Assaad S. Prevalence and factors associated with irritable bowel syndrome among university students in Lebanon: Findings from a cross-sectional study. World J Gastroenterol 2015; 21(12): 3628-3635 [PMID: 25834330 DOI: 10.3748/wjg.v21.i12.3628] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
70 Good L, Rosario R, Panas R. New therapeutic option for irritable bowel syndrome: Serum-derived bovine immunoglobulin. World J Gastroenterol 2015; 21(11): 3361-3366 [PMID: 25805945 DOI: 10.3748/wjg.v21.i11.3361] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
71 Zheng Z, Huang C, Guo Y, Niu K, Momma H, Kobayashi Y, Fukudo S, Nagatomi R. Staple foods consumption and irritable bowel syndrome in Japanese adults: a cross-sectional study. PLoS One 2015;10:e0119097. [PMID: 25785440 DOI: 10.1371/journal.pone.0119097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
72 Wilson N, Schey R. Lubiprostone in constipation: clinical evidence and place in therapy. Ther Adv Chronic Dis 2015;6:40-50. [PMID: 25729555 DOI: 10.1177/2040622314567678] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
73 Altayar O, Sharma V, Prokop LJ, Sood A, Murad MH. Psychological therapies in patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Gastroenterol Res Pract. 2015;2015:549308. [PMID: 25802514 DOI: 10.1155/2015/549308] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
74 Huang XB, Guo TK, Yang YL, Wang H. Linaclotide improves quality of life in patients with irritable bowel syndrome with constipation: A Meta-analysis. Shijie Huaren Xiaohua Zazhi 2015; 23(1): 156-162 [DOI: 10.11569/wcjd.v23.i1.156] [Reference Citation Analysis]
75 Iskandar HN, Cassell B, Kanuri N, Gyawali CP, Gutierrez A, Dassopoulos T, Ciorba MA, Sayuk GS. Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease. J Clin Gastroenterol 2014;48:423-9. [PMID: 24406434 DOI: 10.1097/MCG.0000000000000049] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
76 Knight JR, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Family history of mental illness or alcohol abuse and the irritable bowel syndrome. J Psychosom Res 2015;78:237-41. [PMID: 25582802 DOI: 10.1016/j.jpsychores.2014.11.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
77 Gombash SE, Cowley CJ, Fitzgerald JA, Hall JC, Mueller C, Christofi FL, Foust KD. Intravenous AAV9 efficiently transduces myenteric neurons in neonate and juvenile mice. Front Mol Neurosci 2014;7:81. [PMID: 25360081 DOI: 10.3389/fnmol.2014.00081] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
78 Iorio N, Makipour K, Palit A, Friedenberg FK. Post-traumatic Stress Disorder Is Associated With Irritable Bowel Syndrome in African Americans. J Neurogastroenterol Motil 2014;20:523-30. [PMID: 25273122 DOI: 10.5056/jnm14040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
79 Chmielewska-Wilkoń D, Reggiardo G, Egan CG. Otilonium bromide in irritable bowel syndrome: A dose-ranging randomized double-blind placebo-controlled trial. World J Gastroenterol 2014; 20(34): 12283-12291 [PMID: 25232263 DOI: 10.3748/wjg.v20.i34.12283] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
80 Guo X, Chen J, Lu Y, Wu L, Weng Z, Yang L, Xin Y, Lin X, Liang Y, Fang J. Electroacupuncture at He-Mu points reduces P2X4 receptor expression in visceral hypersensitivity. Neural Regen Res. 2013;8:2069-2077. [PMID: 25206515 DOI: 10.3969/j.issn.1673-5374.2013.22.006] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
81 Yu SW, Rao SS. Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide. Therap Adv Gastroenterol. 2014;7:193-205. [PMID: 25177366 DOI: 10.1177/1756283x14537882] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
82 Yang X, Xi TF, Li YX, Wang HH, Qin Y, Zhang JP, Cai WT, Huang MT, Shen JQ, Fan XM, Shi XZ, Xie DP. Oxytocin decreases colonic motility of cold water stressed rats via oxytocin receptors. World J Gastroenterol 2014; 20(31): 10886-10894 [PMID: 25152590 DOI: 10.3748/wjg.v20.i31.10886] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
83 Lei P, Lei G, Tian J, Zhou Z, Zhao M, Wan C. Development and validation of the irritable bowel syndrome scale under the system of quality of life instruments for chronic diseases QLICD-IBS: combinations of classical test theory and generalizability theory. Int J Colorectal Dis 2014;29:1245-55. [PMID: 25080147 DOI: 10.1007/s00384-014-1976-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
84 Choi YJ, Hwang SW, Kim N, Park JH, Oh JC, Lee DH. Association Between SLC6A4 Serotonin Transporter Gene Lainked Polymorphic Region and ADRA2A -1291C>G and Irritable Bowel Syndrome in Korea. J Neurogastroenterol Motil. 2014;20:388-399. [PMID: 24917480 DOI: 10.5056/jnm14020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
85 Buckley MM, O’Mahony SM, O’Malley D. Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 2014; 20(27): 8846-8858 [PMID: 25083058 DOI: 10.3748/wjg.v20.i27.8846] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
86 Jadallah KA, Kullab SM, Sanders DS. Constipation-predominant irritable bowel syndrome: A review of current and emerging drug therapies. World J Gastroenterol 2014; 20(27): 8898-8909 [PMID: 25083062 DOI: 10.3748/wjg.v20.i27.8898] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
87 Mak GZ, Speaker C, Anderson K, Stiles-Shields C, Lorenz J, Drossos T, Liu DC, Skelly CL. Median arcuate ligament syndrome in the pediatric population. J Pediatr Surg 2013;48:2261-70. [PMID: 24210197 DOI: 10.1016/j.jpedsurg.2013.03.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
88 Muscatello MRA, Bruno A, Scimeca G, Pandolfo G, Zoccali RA. Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome. World J Gastroenterol 2014; 20(24): 7570-7586 [PMID: 24976697 DOI: 10.3748/wjg.v20.i24.7570] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
89 Eswaran S, Guentner A, Chey WD. Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation. J Neurogastroenterol Motil. 2014;20:141-151. [PMID: 24840367 DOI: 10.5056/jnm.2014.20.2.141] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
90 Goepp J, Fowler E, McBride T, Landis D. Frequency of abnormal fecal biomarkers in irritable bowel syndrome. Glob Adv Health Med. 2014;3:9-15. [PMID: 24891989 DOI: 10.7453/gahmj.2013.099] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
91 Jung HK, Kim YH, Park JY, Jang BH, Park SY, Nam MH, Choi MG. Estimating the burden of irritable bowel syndrome: analysis of a nationwide korean database. J Neurogastroenterol Motil. 2014;20:242-252. [PMID: 24840377 DOI: 10.5056/jnm.2014.20.2.242] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
92 Zhu X, Chen W, Zhu X, Shen Y. A cross-sectional study of risk factors for irritable bowel syndrome in children 8-13 years of age in suzhou, china. Gastroenterol Res Pract. 2014;2014:198461. [PMID: 24899889 DOI: 10.1155/2014/198461] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
93 Zhang W, Sun JH, Pei LX, Wu XL, Zhou JL, Chen L. Traditional Chinese medicine for treatment of irritable bowel syndrome: An overview of systematic reviews and Meta-analyses. Shijie Huaren Xiaohua Zazhi 2014; 22(12): 1747-1755 [DOI: 10.11569/wcjd.v22.i12.1747] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
94 Hong SN, Rhee PL. Unraveling the ties between irritable bowel syndrome and intestinal microbiota. World J Gastroenterol 2014; 20(10): 2470-2481 [PMID: 24627584 DOI: 10.3748/wjg.v20.i10.2470] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
95 El-Salhy M, Gilja OH, Gundersen D, Hatlebakk JG, Hausken T. Endocrine cells in the ileum of patients with irritable bowel syndrome. World J Gastroenterol 2014; 20(9): 2383-2391 [PMID: 24605036 DOI: 10.3748/wjg.v20.i9.2383] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
96 Beyder A, Mazzone A, Strege PR, Tester DJ, Saito YA, Bernard CE, Enders FT, Ek WE, Schmidt PT, Dlugosz A, Lindberg G, Karling P, Ohlsson B, Gazouli M, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M, Barbara G, Camilleri M, Locke GR, Talley NJ, D'Amato M, Ackerman MJ, Farrugia G. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome. Gastroenterology. 2014;146:1659-1668. [PMID: 24613995 DOI: 10.1053/j.gastro.2014.02.054] [Cited by in Crossref: 84] [Cited by in F6Publishing: 88] [Article Influence: 10.5] [Reference Citation Analysis]
97 Winston JH, Li Q, Sarna SK. Chronic prenatal stress epigenetically modifies spinal cord BDNF expression to induce sex-specific visceral hypersensitivity in offspring. Neurogastroenterol Motil 2014;26:715-30. [PMID: 24588943 DOI: 10.1111/nmo.12326] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
98 El-Salhy M, Gundersen D, Gilja OH, Hatlebakk JG, Hausken T. Is irritable bowel syndrome an organic disorder? World J Gastroenterol 2014; 20(2): 384-400 [PMID: 24574708 DOI: 10.3748/wjg.v20.i2.384] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 67] [Article Influence: 8.6] [Reference Citation Analysis]
99 Lacy BE, Lembo AJ, Macdougall JE, Shiff SJ, Kurtz CB, Currie MG, Johnston JM. Responders vs clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-C. Neurogastroenterol Motil 2014;26:326-33. [PMID: 24382134 DOI: 10.1111/nmo.12264] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
100 Ma YX, Liu X, Liu CZ, Wang LP, Guo G, Du DQ, Wang ZL, Ma H, Qi P, Li ZF. Randomized clinical trial: the clinical effects of herb-partitioned moxibustion in patients with diarrhoea-predominant irritable bowel syndrome. Evid Based Complement Alternat Med. 2013;2013:605460. [PMID: 24454500 DOI: 10.1155/2013/605460] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
101 Wilson D, Evans M, Weaver E, Shaw AL, Klein GL. Evaluation of serum-derived bovine immunoglobulin protein isolate in subjects with diarrhea-predominant irritable bowel syndrome. Clin Med Insights Gastroenterol 2013;6:49-60. [PMID: 24833942 DOI: 10.4137/CGast.S13200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
102 de Bortoli N, Martinucci I, Bellini M, Savarino E, Savarino V, Blandizzi C, Marchi S. Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol 2013; 19(35): 5787-5797 [PMID: 24124323 DOI: 10.3748/wjg.v19.i35.5787] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
103 Parker CH, Yuan Y, Liu LW. Linaclotide: a new option for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation in adults. Clin Med Insights Gastroenterol 2013;6:21-32. [PMID: 24833940 DOI: 10.4137/CGast.S10550] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
104 Gulewitsch MD, Enck P, Schwille-Kiuntke J, Weimer K, Schlarb AA. Mental Strain and Chronic Stress among University Students with Symptoms of Irritable Bowel Syndrome. Gastroenterol Res Pract. 2013;2013:206574. [PMID: 23843782 DOI: 10.1155/2013/206574] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
105 Reddy YM, Singh D, Nagarajan D, Pillarisetti J, Biria M, Boolani H, Emert M, Chikkam V, Ryschon K, Vacek J, Bommana S, Atkins D, Verma A, Olyaee M, Dawn B, Lakkireddy D. Atrial fibrillation ablation in patients with gastroesophageal reflux disease or irritable bowel syndrome—the heart to gut connection! J Interv Card Electrophysiol 2013;37:259-65. [DOI: 10.1007/s10840-013-9807-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
106 Dong YY, Chen FX, Yu YB, Du C, Qi QQ, Liu H, Li YQ. A school-based study with Rome III criteria on the prevalence of functional gastrointestinal disorders in Chinese college and university students. PLoS One. 2013;8:e54183. [PMID: 23349820 DOI: 10.1371/journal.pone.0054183] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
107 Del Valle-Pinero AY, Van Deventer HE, Fourie NH, Martino AC, Patel NS, Remaley AT, Henderson WA. Gastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution. Clin Chim Acta 2013;418:97-101. [PMID: 23328210 DOI: 10.1016/j.cca.2012.12.032] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
108 Joo YE. Increased Expression of Brain-derived Neurotrophic Factor in Irritable Bowel Syndrome and Its Correlation With Abdominal Pain (Gut 2012; 61: 685-694). J Neurogastroenterol Motil. 2013;19:109-111. [PMID: 23350058 DOI: 10.5056/jnm.2013.19.1.109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
109 Craig OF, Quigley EM. Current and emerging therapies for the management of functional gastrointestinal disorders. Ther Adv Chronic Dis 2011;2:87-99. [PMID: 23251744 DOI: 10.1177/2040622310389507] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
110 Stålhammar NO, Spiegel BM, Granstedt Löfman H, Karlsson M, Wahlqvist P, Næsdal J, Nelson MT, Despiégel N. Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA. Pragmat Obs Res 2012;3:57-67. [PMID: 27774018 DOI: 10.2147/POR.S36704] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
111 Boeckxstaens G, Corazziari ES, Mearin F, Tack J. IBS and the role of otilonium bromide. Int J Colorectal Dis. 2013;28:295-304. [PMID: 23178991 DOI: 10.1007/s00384-012-1598-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
112 Halland M, Talley NJ. New treatments for IBS. Nat Rev Gastroenterol Hepatol. 2013;10:13-23. [PMID: 23147658 DOI: 10.1038/nrgastro.2012.207] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
113 Berger MB, Damico NJ, Menees SB, Fenner DE, Haefner HK. Rates of self-reported urinary, gastrointestinal, and pain comorbidities in women with vulvar lichen sclerosus. J Low Genit Tract Dis 2012;16:285-9. [PMID: 22622339 DOI: 10.1097/LGT.0b013e3182562f1e] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
114 Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher J, Jensen KB, Conboy LA, Kelley JM, Kokkotou E, Kaptchuk TJ. Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One. 2012;7:e48135. [PMID: 23110189 DOI: 10.1371/journal.pone.0048135] [Cited by in Crossref: 130] [Cited by in F6Publishing: 112] [Article Influence: 13.0] [Reference Citation Analysis]
115 Chang HY, Kelly EC, Lembo AJ. Current gut-directed therapies for irritable bowel syndrome. Curr Treat Options Gastroenterol. 2006;9:314-323. [PMID: 16836950 DOI: 10.1007/s11938-006-0013-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
116 Winarni TI, Chonchaiya W, Sumekar TA, Ashwood P, Morales GM, Tassone F, Nguyen DV, Faradz SM, Van de Water J, Cook K, Hamlin A, Mu Y, Hagerman PJ, Hagerman RJ. Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A 2012;158A:2473-81. [PMID: 22903889 DOI: 10.1002/ajmg.a.35569] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
117 Smith TM, Menees SB, Xu X, Saad RJ, Chey WD, Fenner DE. Factors associated with quality of life among women with fecal incontinence. Int Urogynecol J. 2013;24:493-499. [PMID: 22806489 DOI: 10.1007/s00192-012-1889-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
118 Koo HL, Sabounchi S, Huang DB, DuPont HL. Rifaximin therapy of irritable bowel syndrome. Clin Med Insights Gastroenterol 2012;5:31-41. [PMID: 24833932 DOI: 10.4137/CGast.S7382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
119 Wolitzky-Taylor K, Craske MG, Labus JS, Mayer EA, Naliboff BD. Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome. Behav Res Ther 2012;50:647-50. [PMID: 22877888 DOI: 10.1016/j.brat.2012.05.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
120 Olden KW. Targeted therapies for diarrhea-predominant irritable bowel syndrome. Clin Exp Gastroenterol. 2012;5:69-100. [PMID: 22754282 DOI: 10.2147/CEG.S290] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
121 Olden KW. Targeted therapies for diarrhea-predominant irritable bowel syndrome. Clin Exp Gastroenterol. 2012;5:69-100. [PMID: 22754282 DOI: 10.2147/CEG.S29023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
122 Naeem SS, Siddiqui EU, Kazi AN, Memon AA, Khan ST, Ahmed B. Prevalence and factors associated with irritable bowel syndrome among medical students of Karachi, Pakistan: a cross-sectional study. BMC Res Notes. 2012;5:255. [PMID: 22624886 DOI: 10.1186/1756-0500-5-255] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
123 Manheimer E, Cheng K, Wieland LS, Min LS, Shen X, Berman BM, Lao L. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2012;5:CD005111. [PMID: 22592702 DOI: 10.1002/14651858.cd005111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
124 Manheimer E, Cheng K, Wieland LS, Min LS, Shen X, Berman BM, Lao L. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2012;5:CD005111. [PMID: 22592702 DOI: 10.1002/14651858.cd005111.pub3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
125 Manheimer E, Cheng K, Wieland LS, Min LS, Shen X, Berman BM, Lao L. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2012;5:CD005111. [PMID: 22592702 DOI: 10.10002/14651858.CD005111.pub3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Kua CH, Ng ST, Lhode R, Kowalski S, Gwee KA. Irritable bowel syndrome and other gastrointestinal disorders: evaluating self-medication in an Asian community setting. Int J Clin Pharm 2012;34:561-8. [PMID: 22552577 DOI: 10.1007/s11096-012-9644-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
127 Soubra M, Schey R. Lubiprostone for the treatment of adult women with irritable bowel syndrome with constipation. Clin Med Insights Gastroenterol 2012;5:23-30. [PMID: 24833931 DOI: 10.4137/CGast.S7625] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
128 Manheimer E, Wieland LS, Cheng K, Li SM, Shen X, Berman BM, Lao L. Acupuncture for irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2012;107:835-47; quiz 848. [PMID: 22488079 DOI: 10.1038/ajg.2012.66] [Cited by in Crossref: 61] [Cited by in F6Publishing: 70] [Article Influence: 6.1] [Reference Citation Analysis]
129 López-Colombo A, Morgan D, Bravo-González D, Montiel-Jarquín A, Méndez-Martínez S, Schmulson M. The epidemiology of functional gastrointestinal disorders in Mexico: a population-based study. Gastroenterol Res Pract 2012;2012:606174. [PMID: 22474443 DOI: 10.1155/2012/606174] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
130 Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2012;24:521-30, e248. [PMID: 22339879 DOI: 10.1111/j.1365-2982.2012.01891.x] [Cited by in Crossref: 233] [Cited by in F6Publishing: 243] [Article Influence: 23.3] [Reference Citation Analysis]
131 Morgan DR, Benshoff M, Cáceres M, Becker-Dreps S, Cortes L, Martin CF, Schmulson M, Peña R. Irritable bowel syndrome and gastrointestinal parasite infection in a developing nation environment. Gastroenterol Res Pract 2012;2012:343812. [PMID: 22474433 DOI: 10.1155/2012/343812] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
132 Bengtsson M, Hammar O, Mandl T, Ohlsson B. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2011;11:122. [PMID: 22073983 DOI: 10.1186/1471-2393-13-201] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
133 Bengtsson M, Hammar O, Mandl T, Ohlsson B. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2011;11:122. [PMID: 22073983 DOI: 10.1186/1471-230x-11-122] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
134 Barbara G, Cremon C, De Giorgio R, Dothel G, Zecchi L, Bellacosa L, Carini G, Stanghellini V, Corinaldesi R. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep. 2011;13:308-315. [PMID: 21537962 DOI: 10.1007/s11894-011-0195-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 6.3] [Reference Citation Analysis]
135 Walker MM, Warwick A, Ung C, Talley NJ. The role of eosinophils and mast cells in intestinal functional disease. Curr Gastroenterol Rep. 2011;13:323-330. [PMID: 21552990 DOI: 10.1007/s11894-011-0197-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
136 Ringel-Kulka T, Palsson OS, Maier D, Carroll I, Galanko JA, Leyer G, Ringel Y. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol. 2011;45:518-525. [PMID: 21436726 DOI: 10.1097/mcg.0b013e31820ca4d6] [Cited by in Crossref: 99] [Cited by in F6Publishing: 97] [Article Influence: 9.0] [Reference Citation Analysis]
137 Mangualde J, Cremers MI, Vieira AM, Freire R, Gamito &, Lobato C, Alves AL, Augusto F, Oliveira AP. Appropriateness of outpatient gastrointestinal endoscopy in a non-academic hospital. World J Gastrointest Endosc 2011; 3(10): 195-200 [PMID: 22013500 DOI: 10.4253/wjge.v3.i10.195] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
138 Chey WD, Maneerattaporn M, Saad R. Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome. Gut Liver 2011;5:253-66. [PMID: 21927652 DOI: 10.5009/gnl.2011.5.3.253] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
139 Schey R, Rao SS. Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome. Dig Dis Sci. 2011;56:1619-1625. [PMID: 21523369 DOI: 10.1007/s10620-011-1702-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
140 Craske MG, Wolitzky-Taylor KB, Labus J, Wu S, Frese M, Mayer EA, Naliboff BD. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther. 2011;49:413-421. [PMID: 21565328 DOI: 10.1016/jbrat.2011.04.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
141 Craske MG, Wolitzky-Taylor KB, Labus J, Wu S, Frese M, Mayer EA, Naliboff BD. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther. 2011;49:413-421. [PMID: 21565328 DOI: 10.1016/j.brat.2011.04.001] [Cited by in Crossref: 146] [Cited by in F6Publishing: 141] [Article Influence: 13.3] [Reference Citation Analysis]
142 Khan S, Chang L. Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol. 2010;7:565-581. [PMID: 20890316 DOI: 10.1038/nrgastro.2010.137] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 7.1] [Reference Citation Analysis]
143 Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, Kowalczykowski M, Miller FG, Kirsch I, Lembo AJ. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One. 2010;5:e15591. [PMID: 21203519 DOI: 10.1371/journal.pone.0015591] [Cited by in Crossref: 467] [Cited by in F6Publishing: 404] [Article Influence: 38.9] [Reference Citation Analysis]
144 Chang FY, Lu CL, Chen TS. The current prevalence of irritable bowel syndrome in Asia. J Neurogastroenterol Motil. 2010;16:389-400. [PMID: 21103420 DOI: 10.5056/jnm.2010.16.4.389] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 5.8] [Reference Citation Analysis]
145 Burbige EJ. Irritable bowel syndrome: diagnostic approaches in clinical practice. Clin Exp Gastroenterol. 2010;3:127-137. [PMID: 21694856 DOI: 10.2147/ceg.s12596] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
146 Lin JE, Valentino M, Marszalowicz G, Magee MS, Li P, Snook AE, Stoecker BA, Chang C, Waldman SA. Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics. Toxins (Basel) 2010;2:2028-54. [PMID: 22069671 DOI: 10.3390/toxins2082028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
147 Deiteren A, Camilleri M, Burton D, McKinzie S, Rao A, Zinsmeister AR. Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome. Dig Dis Sci. 2010;55:384-391. [PMID: 19949866 DOI: 10.1007/s10620-009-1041-8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
148 Chang JY, Locke GR 3rd, McNally MA, Halder SL, Schleck CD, Zinsmeister AR, Talley NJ. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol. 2010;105:822-832. [PMID: 20160713 DOI: 10.1038/ajg.2010.40] [Cited by in Crossref: 113] [Cited by in F6Publishing: 117] [Article Influence: 9.4] [Reference Citation Analysis]
149 Spiegel BM. The burden of IBS: looking at metrics. Curr Gastroenterol Rep. 2009;11:265-269. [PMID: 19615301 DOI: 10.1007/s11894-009-0039-x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 107] [Article Influence: 7.7] [Reference Citation Analysis]
150 Voci SC, Cramer KM. Gender-related traits, quality of life, and psychological adjustment among women with irritable bowel syndrome. Qual Life Res 2009;18:1169-76. [PMID: 19728159 DOI: 10.1007/s11136-009-9532-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
151 Mathur R, Ko A, Hwang LJ, Low K, Azziz R, Pimentel M. Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome. Dig Dis Sci. 2010;55:1085-1089. [PMID: 19697132 DOI: 10.1007/s10620-009-0890-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
152 McNally MA, Locke GR, Zinsmeister AR, Schleck CD, Peterson J, Talley NJ. Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study. Aliment Pharmacol Ther 2008;28:334-43. [PMID: 19086237 DOI: 10.1111/j.1365-2036.2008.03715.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
153 Lembo AJ, Conboy L, Kelley JM, Schnyer RS, McManus CA, Quilty MT, Kerr CE, Drossman D, Jacobson EE, Davis RB. A treatment trial of acupuncture in IBS patients. Am J Gastroenterol 2009;104:1489-97. [PMID: 19455132 DOI: 10.1038/ajg.2009.156] [Cited by in Crossref: 85] [Cited by in F6Publishing: 68] [Article Influence: 6.5] [Reference Citation Analysis]
154 Liu HR, Wang XM, Zhou EH, Shi Y, Li N, Yuan LS, Wu HG. Acupuncture at both ST25 and ST37 improves the pain threshold of chronic visceral hypersensitivity rats. Neurochem Res. 2009;34:1914-1918. [PMID: 19387829 DOI: 10.1007/s11064-009-9972-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
155 Sweetser S, Camilleri M, Linker Nord SJ, Burton DD, Castenada L, Croop R, Tong G, Dockens R, Zinsmeister AR. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome? Am J Physiol Gastrointest Liver Physiol. 2009;296:G1299-G1306. [PMID: 19342506 DOI: 10.1152/ajpgi.00011.2009] [Cited by in Crossref: 84] [Cited by in F6Publishing: 85] [Article Influence: 6.5] [Reference Citation Analysis]
156 Gasiorowska A, Poh CH, Fass R. Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders? Dig Dis Sci. 2009;54:1829-1834. [PMID: 19082721 DOI: 10.1007/s10620-008-0594-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
157 McOmber MA, Shulman RJ. Pediatric functional gastrointestinal disorders. Nutr Clin Pract 2008;23:268-74. [PMID: 18595859 DOI: 10.1177/0884533608318671] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
158 Savas LS, White DL, Wieman M, Daci K, Fitzgerald S, Laday Smith S, Tan G, Graham DP, Cully JA, El-Serag HB. Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Ther. 2009;29:115-125. [PMID: 18785989 DOI: 10.1111/j.1365-2036.2008.03847.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
159 Ruigómez A, Wallander MA, Johansson S, Rodríguez LA. Irritable bowel syndrome and gastroesophageal reflux disease in primary care: is there a link? Dig Dis Sci. 2009;54:1079-1086. [PMID: 18720002 DOI: 10.1007/s10620-008-0462-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
160 Chang L. The trials and tribulations of drug development for functional gastrointestinal disorders. Neurogastroenterol Motil 2008;20 Suppl 1:130-8. [PMID: 18402650 DOI: 10.1111/j.1365-2982.2008.01093.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
161 Lidén M, Kristjánsson G, Valtysdottir S, Venge P, Hällgren R. Cow’s milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sjögren’s syndrome. Clin Exp Allergy. 2008;38:929-935. [PMID: 18498540 DOI: 10.1111/j.1365-2222.2008.02983.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
162 van Tilburg MA, Palsson OS, Levy RL, Feld AD, Turner MJ, Drossman DA, Whitehead WE. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO. BMC Complement Altern Med 2008;8:46. [PMID: 18652682 DOI: 10.1186/1472-6882-8-46] [Cited by in Crossref: 91] [Cited by in F6Publishing: 84] [Article Influence: 6.5] [Reference Citation Analysis]
163 Halpert A, Dalton CB, Palsson O, Morris C, Hu Y, Bangdiwala S, Hankins J, Norton N, Drossman DA. Patient educational media preferences for information about irritable bowel syndrome (IBS). Dig Dis Sci. 2008;53:3184-3190. [PMID: 18463981 DOI: 10.1007/s10620-008-0280-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
164 Chitkara DK, van Tilburg MA, Blois-Martin N, Whitehead WE. Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review. Am J Gastroenterol 2008;103:765-74; quiz 775. [PMID: 18177446 DOI: 10.1111/j.1572-0241.2007.01722.x] [Cited by in Crossref: 181] [Cited by in F6Publishing: 175] [Article Influence: 12.9] [Reference Citation Analysis]
165 Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N, Whorwell P; Clinical Services Committee of The British Society of Gastroenterology. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007;56:1770-98. [PMID: 17488783 DOI: 10.1136/gut.2007.119446] [Cited by in Crossref: 543] [Cited by in F6Publishing: 483] [Article Influence: 36.2] [Reference Citation Analysis]
166 Arnold LD, Bachmann GA, Rosen R, Kelly S, Rhoads GG. Vulvodynia: characteristics and associations with comorbidities and quality of life. Obstet Gynecol 2006;107:617-24. [PMID: 16507933 DOI: 10.1097/01.AOG.0000199951.26822.27] [Cited by in Crossref: 193] [Cited by in F6Publishing: 172] [Article Influence: 12.9] [Reference Citation Analysis]
167 Chin Feman SP, Nguyen LT, Quilty MT, Kerr CE, Nam BH, Conboy LA, Singer JP, Park M, Lembo AJ, Kaptchuk TJ, Davis RB. Effectiveness of recruitment in clinical trials: an analysis of methods used in a trial for irritable bowel syndrome patients. Contemp Clin Trials 2008;29:241-51. [PMID: 17919993 DOI: 10.1016/j.cct.2007.08.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
168 Park KS, Ahn SH, Hwang JS, Cho KB, Chung WJ, Jang BK, Kang YN, Kwon JH, Kim YH. A survey about irritable bowel syndrome in South Korea: prevalence and observable organic abnormalities in IBS patients. Dig Dis Sci. 2008;53:704-711. [PMID: 17717743 DOI: 10.1007/s10620-007-9930-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
169 Fukudo S. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol. 2007;42 Suppl 17:48-51. [PMID: 17238026 DOI: 10.1007/s00535-006-1942-7] [Cited by in Crossref: 84] [Cited by in F6Publishing: 88] [Article Influence: 5.6] [Reference Citation Analysis]
170 Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007;56:1770-1798. [PMID: 17488783 DOI: 10.1136/gut.2007.119446corr1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
171 Faresjö A, Grodzinsky E, Johansson S, Wallander MA, Timpka T, Akerlind I. Psychosocial factors at work and in every day life are associated with irritable bowel syndrome. Eur J Epidemiol. 2007;22:473-480. [PMID: 17484023 DOI: 10.1007/s10654-007-9133-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
172 Caffarelli C, Coscia A, Baldi F, Borghi A, Capra L, Cazzato S, Migliozzi L, Pecorari L, Valenti A, Cavagni G. Characterization of irritable bowel syndrome and constipation in children with allergic diseases. Eur J Pediatr 2007;166:1245-52. [PMID: 17345097 DOI: 10.1007/s00431-006-0410-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
173 Simrén M, Agerforz P, Björnsson ES, Abrahamsson H. Nutrient-dependent enhancement of rectal sensitivity in irritable bowel syndrome (IBS). Neurogastroenterol Motil. 2007;19:20-29. [PMID: 17187585 DOI: 10.1111/j.1365-2982.2006.00849.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
174 Fukudo S. Sex and gender in irritable bowel syndrome. J Gastroenterol 2006;41:608-10. [PMID: 16868814 DOI: 10.1007/s00535-006-1859-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
175 Shiotani A, Miyanishi T, Takahashi T. Sex differences in irritable bowel syndrome in Japanese university students. J Gastroenterol. 2006;41:562-568. [PMID: 16868804 DOI: 10.1007/s00535-006-1805-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
176 Ouyang A, Wrzos HF. Contribution of gender to pathophysiology and clinical presentation of IBS: should management be different in women? Am J Gastroenterol 2006;101:S602-9. [PMID: 17177863 DOI: 10.1111/j.1572-0241.2006.00975.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
177 Minocha A, Johnson WD, Abell TL, Wigington WC. Prevalence, sociodemography, and quality of life of older versus younger patients with irritable bowel syndrome: a population-based study. Dig Dis Sci 2006;51:446-53. [PMID: 16614950 DOI: 10.1007/s10620-006-3153-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
178 Robinson A, Lee V, Kennedy A, Middleton L, Rogers A, Thompson DG, Reeves D. A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome. Gut 2006;55:643-8. [PMID: 16099784 DOI: 10.1136/gut.2004.062901] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 4.1] [Reference Citation Analysis]
179 charapata C, mertz H. Physician knowledge of Rome symptom criteria for irritable bowel syndrome is poor among non-gastroenterologists. Neurogastroenterol Motil 2006;18:211-6. [DOI: 10.1111/j.1365-2982.2005.00750.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
180 Brandt LJ, Prather CM, Quigley EM, Schiller LR, Schoenfeld P, Talley NJ. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 2005;100 Suppl 1:S5-S21. [PMID: 16008641 DOI: 10.1111/j.1572-0241.2005.50613_2.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 162] [Article Influence: 10.7] [Reference Citation Analysis]
181 Celebi S, Acik Y, Deveci SE, Bahcecioglu IH, Ayar A, Demir A, Durukan P. Epidemiological features of irritable bowel syndrome in a Turkish urban society. J Gastroenterol Hepatol. 2004;19:738-743. [PMID: 15209618 DOI: 10.1111/j.1440-1746.2004.03367.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
182 Chey WD, Chey WY, Heath AT, Dukes GE, Carter EG, Northcutt A, Ameen VZ. Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2004;99:2195-203. [PMID: 15555002 DOI: 10.1111/j.1572-0241.2004.30509.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 102] [Article Influence: 5.8] [Reference Citation Analysis]
183 Yeo A, Boyd P, Lumsden S, Saunders T, Handley A, Stubbins M, Knaggs A, Asquith S, Taylor I, Bahari B, Crocker N, Rallan R, Varsani S, Montgomery D, Alpers DH, Dukes GE, Purvis I, Hicks GA. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 2004;53:1452-8. [PMID: 15361494 DOI: 10.1136/gut.2003.035451] [Cited by in Crossref: 178] [Cited by in F6Publishing: 169] [Article Influence: 9.9] [Reference Citation Analysis]
184 Li TJ, Yu BP, Dong WG, Luo HS, Xu L, Li MQ. Ovarian hormone modulates 5-hydroxytryptamine 3 receptors mRNA expression in rat colon with restraint stress-induced bowel dysfunction. World J Gastroenterol 2004; 10(18): 2723-2726 [PMID: 15309727 DOI: 10.3748/wjg.v10.i18.2723] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
185 Xiao WB, Liu YL. Rectal hypersensitivity reduced by acupoint TENS in patients with diarrhea-predominant irritable bowel syndrome: a pilot study. Dig Dis Sci. 2004;49:312-319. [PMID: 15104377 DOI: 10.1023/b:ddas.0000017458.55517.33] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]
186 Xiao WB, Liu YL. Rectal hypersensitivity reduced by acupoint TENS in patients with diarrhea-predominant irritable bowel syndrome: a pilot study. Dig Dis Sci. 2004;49:312-319. [PMID: 15104377 DOI: 10.1023/b: ddas.0000017458.55517.33] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
187 Si JM, Wang LJ, Chen SJ, Sun LM, Dai N. Irritable bowel syndrome consulters in Zhejiang province: The symptoms pattern, predominant bowel habit subgroups and quality of life. World J Gastroenterol 2004; 10(7): 1059-1064 [PMID: 15052694 DOI: 10.3748/wjg.v10.i7.1059] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
188 Bellini M, Rappelli L, Blandizzi C, Costa F, Stasi C, Colucci R, Giannaccini G, Marazziti D, Betti L, Baroni S. Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron. Am J Gastroenterol. 2003;98:2705-2711. [PMID: 14687821 DOI: 10.1111/j.1572-0241.2003.08669.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
189 Kalantar JS, Locke GR 3rd, Zinsmeister AR, Beighley CM, Talley NJ. Familial aggregation of irritable bowel syndrome: a prospective study. Gut 2003;52:1703-7. [PMID: 14633946 DOI: 10.1136/gut.52.12.1703] [Cited by in Crossref: 115] [Cited by in F6Publishing: 107] [Article Influence: 6.1] [Reference Citation Analysis]
190 Berrada D, Canenguez K, Lembo T. New approaches to the medical treatment of irritable bowel syndrome. Curr Gastroenterol Rep. 2003;5:337-342. [PMID: 12864965 DOI: 10.1007/s11894-003-0072-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
191 Xu XX, Li DG, Song GH, Zhou HQ, Liu QH. Time cluster and symptom character of 402 outpatients with irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2003; 11(8): 1234-1236 [DOI: 10.11569/wcjd.v11.i8.1234] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
192 Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol. 2003;98:1064-1072. [PMID: 12809829 DOI: 10.1111/j.1572-0241.2003.07285.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 67] [Article Influence: 0.7] [Reference Citation Analysis]